Literature DB >> 21826010

Barriers to antiretroviral initiation in HIV-1-discordant couples.

Brandon L Guthrie1, Robert Y Choi, Amy Y Liu, Romel D Mackelprang, Anne F Rositch, Rose Bosire, Lucy Manyara, Ann Gatuguta, James N Kiarie, Carey Farquhar.   

Abstract

BACKGROUND: In Kenya and much of sub-Saharan Africa, nearly half of all couples affected by HIV are discordant. Antiretroviral therapy (ART) slows disease progression in HIV-1-infected individuals and reduces transmission to uninfected partners. We examined time to ART initiation and factors associated with delayed initiation in HIV-1-discordant couples in Nairobi.
METHODS: HIV-1-discordant couples were enrolled and followed quarterly for up to 2 years. Clinical staff administered questionnaires and conducted viral loads and CD4 counts. Participants with a CD4 count meeting ART criteria were referred to a nearby US President's Emergency Plan for AIDS Relief-funded treatment center. Barriers to ART initiation among participants with a CD4 count eligible for ART were assessed by Cox regression.
RESULTS: Of 439 HIV-1-infected participants (63.6% females and 36.4% males), 146 met CD4 count criteria for ART during follow-up. Median time from meeting CD4 criteria until ART initiation was 8.9 months, with 42.0% of eligible participants on ART by 6 months and 63.4% on ART by 1 year. The CD4 count at the time of eligibility was inversely associated with time to ART initiation (hazard ratio = 0.49, P < 0.001). Compared with homeowners, those paying higher rents started ART 48% more slowly (P = 0.062) and those paying lower rents started 71% more slowly (P = 0.002).
CONCLUSIONS: Despite access to regular health care, referrals to treatment centers, and free access to ART, over one-third of participants with an eligible CD4 count had not started ART within 1 year. Factors of lower socioeconomic status may slow ART initiation, and targeted approaches are needed to avoid delays in treatment initiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826010      PMCID: PMC3202340          DOI: 10.1097/QAI.0b013e31822f064e

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  21 in total

1.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Authors:  Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum
Journal:  Lancet       Date:  2010-05-26       Impact factor: 79.321

2.  Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.

Authors:  S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

4.  Predicting pregnancy in HIV-1-discordant couples.

Authors:  Brandon L Guthrie; Robert Y Choi; Rose Bosire; James N Kiarie; Romel D Mackelprang; Anne Gatuguta; Grace C John-Stewart; Carey Farquhar
Journal:  AIDS Behav       Date:  2010-10

5.  HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.

Authors:  Steven J Reynolds; Frederick Makumbi; Gertrude Nakigozi; Joseph Kagaayi; Ronald H Gray; Maria Wawer; Thomas C Quinn; David Serwadda
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

6.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

7.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.

Authors:  Jairam R Lingappa; James P Hughes; Richard S Wang; Jared M Baeten; Connie Celum; Glenda E Gray; Wendy S Stevens; Deborah Donnell; Mary S Campbell; Carey Farquhar; M Essex; James I Mullins; Robert W Coombs; Helen Rees; Lawrence Corey; Anna Wald
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

8.  Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda.

Authors:  Putu Duff; Walter Kipp; T Cameron Wild; Tom Rubaale; Joa Okech-Ojony
Journal:  J Int AIDS Soc       Date:  2010-09-23       Impact factor: 5.396

9.  Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.

Authors:  E Vittinghoff; S Scheer; P O'Malley; G Colfax; S D Holmberg; S P Buchbinder
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

10.  Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa.

Authors:  Bruce A Larson; Alana Brennan; Lynne McNamara; Lawrence Long; Sydney Rosen; Ian Sanne; Matthew P Fox
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

View more
  16 in total

1.  HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Authors:  Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

2.  'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.

Authors:  Kathryn Curran; Kenneth Ngure; Bettina Shell-Duncan; Sophie Vusha; Nelly R Mugo; Renee Heffron; Connie Celum; Jared M Baeten
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

3.  Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships.

Authors:  Andrew Mujugira; Connie Celum; Katherine K Thomas; Carey Farquhar; Nelly Mugo; Elly Katabira; Elizabeth A Bukusi; Elioda Tumwesigye; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

Review 4.  HIV-1 prevention for HIV-1 serodiscordant couples.

Authors:  Kathryn Curran; Jared M Baeten; Thomas J Coates; Ann Kurth; Nelly R Mugo; Connie Celum
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

5.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

6.  Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.

Authors:  Christopher J Hoffmann; James J Lewis; David W Dowdy; Katherine L Fielding; Alison D Grant; Neil A Martinson; Gavin J Churchyard; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

7.  Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS.

Authors:  Tara Vijayan; Fred C Semitala; Nicholas Matsiko; Patrick Elyanu; Jennifer Namusobya; Diane V Havlir; Moses Kamya; Elvin H Geng
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

8.  Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.

Authors:  Andrew Mujugira; Connie Celum; Jordan W Tappero; Allan Ronald; Nelly Mugo; Jared M Baeten
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

9.  Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study.

Authors:  Ingrid T Katz; Janan Dietrich; Gugu Tshabalala; Thandekile Essien; Kathryn Rough; Alexi A Wright; David R Bangsberg; Glenda E Gray; Norma C Ware
Journal:  AIDS Behav       Date:  2015-04

Review 10.  Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.

Authors:  Mona R Loutfy; Wei Wu; Michelle Letchumanan; Lise Bondy; Tony Antoniou; Shari Margolese; Yimeng Zhang; Sergio Rueda; Frank McGee; Ryan Peck; Louise Binder; Patricia Allard; Sean B Rourke; Paula A Rochon
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.